HOWL

Werewolf Therapeutics, Inc.

• Benzinga·5d ago

  Why e.l.f. Beauty Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

• Simply Wall St·05/14 10:58

  Here's Why We're A Bit Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Situation

• PUBT·05/13 20:07

  Werewolf Therapeutics director Luke Evnin sells 44,679 shares worth $24,127.66

• TipRanks·05/13 02:07

  Major Werewolf Therapeutics Stakeholder Makes a Big Move on Wall Street

• PUBT·05/12 23:48

  Werewolf Therapeutics director Luke Evnin disposes 407,574 shares for $294,971.41

• PUBT·05/12 22:27

  RA Capital Management disposes 565,167 Werewolf Therapeutics shares worth $389,277

• NASDAQ·05/08 10:45

  Werewolf Reports Q1 Loss Of $13 Mln, Highlights Asset Purchase Agreement With Jazz

• PUBT·05/07 22:39

  Werewolf Therapeutics director Luke Evnin disposes of USD 63,622 common shares

• Seeking Alpha·05/07 21:47

  Werewolf Therapeutics GAAP EPS of -$0.28 beats by $0.01

• Benzinga·05/07 20:45

  Werewolf Therapeutics Q1 EPS $(0.28), Inline

• PUBT·05/07 20:27

  Werewolf Therapeutics Q1 net loss narrows to $13.5 million; R&D expenses drop to $8.2 million

• Dow Jones·05/07 20:05

  Press Release: Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates

• PUBT·05/04 22:00

  Werewolf Therapeutics director Luke Evnin disposes of common shares worth $198,028.71

• PUBT·04/29 23:17

  Werewolf Therapeutics director Luke Evnin disposes of $149,559 common shares

• Benzinga·04/28 17:05

  12 Health Care Stocks Moving In Tuesday's Intraday Session